From the Guidelines
In patients with Conn's syndrome, also known as primary aldosteronism, lab findings typically include elevated serum aldosterone levels, often exceeding 20 ng/dL, and suppressed plasma renin activity, usually below 1.0 ng/mL/h [ 1, 2, 3, 4, 5 ].
Key Lab Findings
- Hypokalemia, with serum potassium levels often below 3.5 mmol/L
- Metabolic alkalosis, with elevated serum bicarbonate levels
- Elevated aldosterone-to-renin ratio (ARR), typically above 30, which can be used as a screening test for the condition [ 1, 2, 3, 4, 5 ] ### Important Considerations
- The ARR result needs to be interpreted in the context of the specific medication(s) the patient is taking [ 1 ]
- Hypokalemia is absent in the majority of cases and has a low negative predictive value for the diagnosis of primary aldosteronism [ 5 ]
- The diagnosis of primary aldosteronism generally requires a confirmatory test, such as the intravenous saline suppression test or oral salt-loading test [ 4 ]
From the Research
Lab Findings in Conn's Syndrome
The lab findings in Conn's syndrome, also known as primary aldosteronism, include:
- Elevated aldosterone levels 6, 7, 8, 9, 10
- Low plasma renin activity (PRA) 7, 8, 9, 10
- High aldosterone to renin ratio (ARR) 6, 7, 8
- Hypokalemia (low serum potassium levels) 6, 7, 8, 9, 10
- Hypernatremia (high serum sodium levels) 10
- Elevated creatinine phosphokinase (CPK) levels in cases of rhabdomyolysis 9
Diagnostic Tests
The following diagnostic tests are used to confirm primary aldosteronism:
- Measurement of the aldosterone-renin ratio (ARR) as a first screening test 6, 7, 8
- Aldosterone suppression testing to confirm inappropriate aldosterone secretion 8
- Imaging of the adrenal glands to differentiate between unilateral and bilateral adrenal disease 6
- Selective adrenal vein catheterization as the current gold standard for diagnosis 6
- Functional imaging techniques and measurement of steroid profiles as promising alternatives to adrenal vein catheterization 6
Subtype Evaluation
The following tests are used to evaluate the subtype of primary aldosteronism: